Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05836597 · ClinicalTrials.gov registry record · NA
Functional Dyspepsia Treatment Using Virtual Reality
A NA study of Functional Dyspepsia, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT05836597: Recruiting NA study of Functional Dyspepsia, sponsored by Mayo Clinic.
NCT05836597 is a NA study of Functional Dyspepsia that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 30 participants, below the 70-participant average among 9 other Functional Dyspepsia trials with a reported enrollment target (57% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05836597, a NA study of Functional Dyspepsia, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to evaluate the effectiveness of using virtual reality to treat gastrointestinal symptoms related to functional dyspepsia.
Primary Outcome
Measured by the Patient Assessment of Gastrointestinal Disorders-Symptom Severity Index (PAGI-SYM) questionnaire individual scores for abdominal pain. Scored 0-5, with higher scores representing more severe symptoms.
Conditions Studied
Interventions
- DEVICE Virtual reality
Study Locations (1)
Florida
- Mayo Clinic in Florida - Jacksonville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2024-04-01 |
| Est. Completion | 2026-12 |
| Phase | NA |
What NCT05836597 shows while recruiting
NCT05836597 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 70-participant average among 9 other Functional Dyspepsia trials with a reported enrollment target (57% lower).
The record links to 1 condition, with Functional Dyspepsia appearing as the primary indexed condition, and to 1 intervention - of which Virtual reality is the first listed.
NCT05836597 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT05836597 about?
NCT05836597 is a clinical study titled "Functional Dyspepsia Treatment Using Virtual Reality". The purpose of this study is to evaluate the effectiveness of using virtual reality to treat gastrointestinal symptoms related to functional dyspepsia.
What is the current status of trial NCT05836597?
This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2024-04-01. Estimated completion is 2026-12.
What conditions does trial NCT05836597 study?
This clinical trial studies the following conditions: Functional Dyspepsia.
What interventions are being tested in trial NCT05836597?
The interventions under investigation include: Virtual reality (DEVICE).
Who is sponsoring clinical trial NCT05836597?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05836597 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Functional Dyspepsia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05836597's enrollment target sits among peer trials
30 7th of 9 higher than 3 of 9 other Functional Dyspepsia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Functional Dyspepsia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Synergistic Gut-brain Axis Modulation Via Vagal Stimulation and Support Therapy in Functional Dyspepsia
RECRUITING · NA
-
Exposure-Based CBT for Avoidant/Restrictive Food Intake in Functional Dyspepsia
RECRUITING · NA
-
Autonomic Reactivity and Personalized Neurostimulation
RECRUITING · NA
-
Brain-Gut Yoga for Functional Dyspepsia and Gastroparesis (FD-GP)
RECRUITING · NA
-
Cerebral Cortical Influences on Autonomic Function
ACTIVE NOT RECRUITING · NA
-
Ketotifen for Children With Functional Dyspepsia in Association With Duodenal Eosinophilia
RECRUITING · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI